Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Myasthenia Gravis”

325 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 325 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06558279
What this trial is testing

Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Ocular
argenx 141
Not applicableUnknownNCT04674605
What this trial is testing

A Prospective Cohort Study Of Myasthenia Gravis

Who this might be right for
Myasthenia GravisMyasthenia Gravis Crisis
First Affiliated Hospital of Chongqing Medical University 200
Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Testing effectiveness (Phase 2)Looking for participantsNCT07250750
What this trial is testing

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
ImmunAbs Inc. 96
Post-approval studies (Phase 4)Study completedNCT01179893
What this trial is testing

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

Who this might be right for
Myasthenia Gravid
University Health Network, Toronto 87
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096
What this trial is testing

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 261
Not applicableStudy completedNCT02761707
What this trial is testing

Biomarkers in Neural Disorders

Who this might be right for
Parkinson's DiseaseAlzheimer's DiseaseProgressive Supranuclear Palsy+6 more
University of Pennsylvania 54
Testing effectiveness (Phase 2)Ended earlyNCT02102594
What this trial is testing

Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)

Who this might be right for
Myasthenia GravisSystemic Lupus ErythematosusRheumatoid Arthritis
Charite University, Berlin, Germany 11
Not applicableStudy completedNCT02118805
What this trial is testing

Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Myasthenia GravisMyopathies+2 more
Beth Israel Deaconess Medical Center 100
Not applicableLooking for participantsNCT06940323
What this trial is testing

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

Who this might be right for
Multiple SclerosisClinically Isolated SyndromeNMOSD+1 more
University of California, San Francisco 250
Very early researchEnded earlyNCT03059888
What this trial is testing

Trial of Orencia in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Johns Hopkins University 6
Large-scale testing (Phase 3)Looking for participantsNCT06607627
What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Enrolling By InvitationNCT06435312
What this trial is testing

An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Not applicableNo Longer AvailableNCT00704925
What this trial is testing

Treatment of Lambert-Eaton Syndrome With 3,4 DAP

Who this might be right for
Lambert Eaton Myasthenic Syndrome
David P. Richman, MD
Not applicableStudy completedNCT05992025
What this trial is testing

Digital Phenotyping and Lifestyle Intervention in Patients with Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Uppsala University 83
Large-scale testing (Phase 3)Looking for participantsNCT06744920
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Novartis Pharmaceuticals 180
Testing effectiveness (Phase 2)Study completedNCT03052751
What this trial is testing

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
UCB Biopharma S.P.R.L. 43
Large-scale testing (Phase 3)Study completedNCT03770403
What this trial is testing

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

Who this might be right for
Generalized Myasthenia Gravis
argenx 151
Not applicableActive Not RecruitingNCT07071246
What this trial is testing

Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis

Who this might be right for
Treatment
Tang-Du Hospital 30
Load More Results